抄読会;田村dr Current status of molecularly targeted drugs for the treatment of advanced thyroid cancer.

Current status of molecularly targeted drugs for the treatment of advanced thyroid cancer.

http://www.ncbi.nlm.nih.gov/pubmed/21383525

vandetanib
XL-184
sorafenib
motesanib
axitinib
pazopanib